AFLD 2007 FFC vs Respondent M30

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M30 for a violation of the Anti-Doping Rules. During a cycling event on September 10, 2006, a sample was taken for doping control purposes. Analysis of the sample showed the presence of salbutamol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had used a pharmaceutical product containing the prohibited substance to treat asthma, this was mentioned on the doping control form. He has a prescription for the pharmaceutical product also a certificate from his physician and medical reports to prove his medical state. The panel regards the prescription and the medical papers as a medical justification for using salbutamol.

Decision
1. The respondent is acquitted.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
10 May 2007
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Asthma
Legitimate Medical Treatment
Document type
Pdf file
Date generated
24 July 2014
Date of last modification
25 September 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin